Ajooni Biotech MD, chairman and AGM

Ajooni Biotech board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

Chairperson and managing directorJASJOT SINGHRelated to the promoter
Company Secretary and Compliance OfficerSwati Vijan

7 directors4 independent3 executive

JASJOT SINGH · Chairperson and managing directorExecutive · joined Dec 2013 · reappointed Apr 2025 · 60 months as independent · 1 listed board
GURSIMRAN SINGHExecutive · joined Aug 2022 · reappointed Aug 2025 · 60 months as independent · 1 listed board
PARTEK SINGHExecutive · joined Jun 2017 · reappointed Jun 2017 · 1 listed board
RAMANDEEP SINGHIndependent · joined Aug 2017 · reappointed Aug 2022 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat
IMTESHWAR SINGH BHATIAIndependent · joined Aug 2017 · reappointed Aug 2022 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat
SIMMI CHHABRAIndependent · joined Aug 2017 · reappointed Aug 2022 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
ISHTNEET BHATIAIndependent · joined Jan 2025 · reappointed Feb 2025 · 60 months as independent · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

Board
- 14 Aug 20267 of 7 present4 independent · 1 day in between
- 12 Aug 20267 of 7 present4 independent · 43 days in between
- 29 Jun 20267 of 7 present4 independent · 31 days in between
- 28 May 20267 of 7 present4 independent · 6 days in between
1 earlier meeting
- 21 May 20267 of 7 present4 independent
Audit Committee
Chair SIMMI CHHABRA
IMTESHWAR SINGH BHATIA, RAMANDEEP SINGH
- 12 Aug 20263 of 3 present3 independent · 49 days in between
- 21 May 20263 of 3 present3 independent · 6 days in between
Nomination and remuneration committee
Chair SIMMI CHHABRA
IMTESHWAR SINGH BHATIA, RAMANDEEP SINGH
- 23 Jun 20263 of 3 present3 independent · 32 days in between
- 14 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair SIMMI CHHABRA
IMTESHWAR SINGH BHATIA, RAMANDEEP SINGH
No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

NARINDER KUMAR AND COMPANYPeer-review certificate valid to Nov 2026

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Ajooni Biotech AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Ajooni Biotech share news and announcements

Annual general meeting, 29 Jul 2026

60,449 shareholders on the register on 17 Jul 2026; present: 5 promoters and 46 others; votes counted by MAST RAM CHECHI / M.R. CHECHI AND ASSOCIATES.The company's voting result (opens in a new tab)

To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended 31st March, 2026, together with the Reports of the Board of Directors and Auditors thereon.
Ordinary
99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.14%
Turnout: all 30.40% · promoters 100.00% · institutions 0.00% · other public 4.79%
To re-appoint a Director in place of Mr. Gursimran Singh (DIN: 02209675) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Ordinary
99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.14%
Turnout: all 30.39% · promoters 100.00% · institutions 0.00% · other public 4.79%
To increase the authorized share capital
Special
99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 0.15%
Turnout: all 30.40% · promoters 100.00% · institutions 0.00% · other public 4.79%
To issue equity shares on a preferential basis.
SpecialPromoters have an interest in it
99.83% for0.18% against
Against: promoters 0.00% · institutions 0.00% · other public 0.18%
Turnout: all 3.02% · promoters 0.00% · institutions 0.00% · other public 4.14%